

It has been another busy week for Australiaâs top brokers. This has led to the release of a large number of broker notes.
Three broker buy ratings that you might want to know more about are summarised below. Hereâs why brokers think these ASX shares are in the buy zone:
Blackmores Ltd (ASX: BKL)
According to a note out of Credit Suisse, its analysts have upgraded this health supplements companyâs shares to an outperform rating with a $90.00 price target. Although the broker was not overly impressed with Blackmoresâ full year results, it believes that its shares have fallen to an attractive level with more upside potential than downside risk. The Blackmores share price is trading at $71.09 today.
CSL Limited (ASX: CSL)
A note out of Macquarie reveals that its analysts have retained their outperform rating and lifted their price target on this biotherapeutics companyâs shares to $329.50. Macquarie was pleased with the companyâs guidance for FY 2023 and believes it is well-placed to build on this in FY 2024. Particularly given improving trading conditions and the new Rika plasma collection platform. The CSL share price is fetching $294.63 on Friday.
Pro Medicus Limited (ASX: PME)
Analysts at Morgans have retained their add rating and lifted their price target on this health imaging technology companyâs shares to $58.18. This follows the release of a strong result for FY 2022 earlier this week. Morgans was particularly pleased with the companyâs margins, which were well ahead of expectations. It feels this highlights the operating leverage of the business. The broker also notes that the companyâs outlook remains as strong as ever, highlighted by an increasing number of requests for tender proposals. The Pro Medicus share price is trading at $54.00 today.
The post Brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now
See The 5 Stocks
*Returns as of August 4 2022
(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}
setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()
More reading
- Buy this ASX 200 company as its costs are actually falling: Firetrail
- Blackmores share price dives 10% despite revenue boost
- Here are the top 10 ASX 200 shares today
- Why Blackmores, Codan, Lake Resources, and Xero shares are falling today
- Why CSL, IPH, Renascor, and Treasury Wine shares are pushing higher
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. and Pro Medicus Ltd. The Motley Fool Australia has positions in and has recommended Pro Medicus Ltd. The Motley Fool Australia has recommended Blackmores Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/zIsQYVP
Leave a Reply